L their recent report M. Piatak et al. found high concentrations of RNA from human immunodeficiency virus-type 1 (HIV-1) (up to 22 million RNA genomes per milliliter) in the plasma of each of the 66 seropositive patients they evaluated (1) . This concentration, as determined by their "quantitative competitive polymerase chain reaction" (QC-PCR) assay (1), was highly correlated with CD4' T As part of a project to investigate the feasibility of inducing viral depletion or inactivation in blood for transfusion, we have studied the compartmentalization of HIV-1 in blood. We found that platelets subjected to filtration (to remove leukocytes) and to serial washes (to remove plasma) retained high concentrations of tightly associated HIV-1 RNA; presumably this reflected bound viral particles. The concentrations of virus associated with platelets frequently exceeded those free in plasma by a factor of ten or more.
When we used the protocol of Piatak et al. to process 15 blood samples (centrifugation at 200g for 15 min; 1000g for 15 min), we found that plasma specimens (which they would designate "cell-free") in fact contained an average of 7 x 106 platelets per milliliter (range, 3 to 14 x 106 platelets per milliliter). Six of these samples (from four HIV-1 seropositive subjects) were further processed (in a step not taken by Piatak et al.) by centrifugation at 10,000g for 15 min to yield platelet pellets and plasma samples that were truly platelet-free (Fig. 1 ). We also prepared purified platelets from these patients by centrifugation of whole blood at 250g for 5 min. leukodepletion of the platelet-rich plasma (PL-F1 filters, Pall, Glen Cove, New York), pelleting of platelets at 10,000g for 15 min, and five washes of the pellet to remove plasma. The platelet-free plasma and the two platelet pellets from each sample were then assayed in parallel to detect HIV-1 RNA with the use of a sensitive RT-PCR assay (2). To recover virions from the cell-free plasma, we used an immunocapture technique with anti-gp-120/41-coated latex microparticles (2) . AS-2 cell-free supernatants, which had no detectable residual platelets, were subjected to immunocapture RT-PCR in duplicate (lanes 1 and 2) (2), and the platelet pellets were lysed and assayed in parallel by RT-PCR (lanes 3 and 4) .
PC-i P0-2 HIV(-) pits
Purified platelet pellets (lanes 5 and 6), prepared from 100 microliter of platelet-rich plasma (170,000 and 140,000 platelets per microliControls ter, respectively) after leukocyte filtration and serial washes, were also assayed in parallel (lanes 5 and 6). Known HIV-1 viral particle standards [PC-1 (1000 copies per milliliter) and PC-2 (100 copies per milliliter)] were processed in parallel. As a control, a purified platelet pellet from 100 microliters of platelet-rich plasma from a seronegative person was tested in parallel under code HIV(-) pits.
Purified platelets (depleted of leukocytes and plasma), recovered from 100 p.l of platelet-rich plasma, harbored much more virus than was present in platelet-free plasma (Fig. 1) . These purified platelet preparations did not contain HIV-1 DNA as determined by a sensitive assay system (3) , which showed that the HIV-1 RNA 
